This list is an analysis based on recent market events. It's not an investment recommendation.
About
Human Metabolome Technologies, Inc., biotechnology company, develops metabolomics technologies and solutions for drug discovery, diagnosis, and food production in Japan. The company provides metabolome analysis services; and global profiling, targeted assays, flux analysis, and lipidomics services. It also develops biomarkers, such as Phosphorylethanolamine, a biomarker for major depressive disorder and measured in blood plasma. The company offers solutions for cancer metabolism, metabolic flux analysis, infectious diseases, basic science, preclinical and clinical, food and nutrition, and microbiome applications. It has a collaboration with the Institute for Advanced Biosciences and Keio University for the development of metabolome analysis technology. The company was incorporated in 2003 and is headquartered in Tsuruoka, Japan.
What is Human Metabolome Technologies stock price today?▼
The current price of 6090.TSE is ¥699 JPY — it has decreased by -0.57% in the past 24 hours. Watch Human Metabolome Technologies stock price performance more closely on the chart.
What is Human Metabolome Technologies stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Human Metabolome Technologies stocks are traded under the ticker 6090.TSE.
What is Human Metabolome Technologies market cap?▼
Today Human Metabolome Technologies has the market capitalization of 4.14B
When is the next Human Metabolome Technologies earnings date?▼
Human Metabolome Technologies is going to release the next earnings report on May 13, 2026.
What were Human Metabolome Technologies earnings last quarter?▼
6090.TSE earnings for the last quarter are 24.22 JPY per share, whereas the estimation was N/A JPY resulting in a N/A surprise. The estimated earnings for the next quarter are N/A JPY per share.
What is Human Metabolome Technologies revenue for the last year?▼
Human Metabolome Technologies revenue for the last year amounts to 3.62B JPY.
What is Human Metabolome Technologies net income for the last year?▼
6090.TSE net income for the last year is 685.04M JPY.
Does Human Metabolome Technologies pay dividends?▼
Yes, 6090.TSE dividends are paid semi-annual. The last dividend per share was 15 JPY. As of today, Dividend Yield (FWD)% is 2.56%.
In which sector is Human Metabolome Technologies located?▼
Human Metabolome Technologies operates in the Healthcare sector.
When did Human Metabolome Technologies complete a stock split?▼
Human Metabolome Technologies has not had any recent stock splits.
Where is Human Metabolome Technologies headquartered?▼
Human Metabolome Technologies is headquartered in Tsuruoka, JP.